Treventis Corporation
- Biotech or pharma, therapeutic R&D
Small molecule drug company with an R&D pipeline targeting misfolded proteins for treating AD, tauopathies, ALS/FTD and cancer. Treventis’ drug discovery platform has generated disease-modifying drugs with unique MOA for use in neurology and oncology
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}